Before Wednesday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst commentary for investors.
C.R. Bard Downgraded at Barclays
C.R. Bard, Inc. (BCR) has been cut to “Equal Weight” at Barclays. BCR has a dividend yield of 0.64%.
Franklin Resources Upgraded to “Buy”
Franklin Resources, Inc. (BEN) has been upgraded from “Neutral” to “Buy” at Goldman Sachs due to better flow trends driven by emerging markets. BEN has a dividend yield of 0.85%.
JP Morgan Downgrades GNC
JP Morgan has lowered its rating on GNC Holdings Inc (GNC) to “Neutral” as the company is seeing weak sales and its CFO has departed. GNC has a dividend yield of 1.82%.
The Gap Upgraded to “Buy”
The Gap Inc. (GPS) has been raised to “Buy” at Canaccord Genuity as the company can continue to expand margins. The firm has a $51 price target on GPS, suggesting a 24% upside from Tuesday’s closing price of $41.24. GPS has a dividend yield of 2.13%.
Barclays Upgrades Medtronic
Following several analysts’ upgrades on Tuesday, Barclays has upgraded Medtronic, Inc. (MDT) from “Equal Weight” to “Overweight.” The upgrade was due to the company’s deal to acquire Covidien (COV). MDT has